Prot #mRNA-2416-P101: A Phase I/II, Open-Label, Multicenter, Dose Escalation and Efficacy Study of mRNA 2416, a Lipid Nanoparticle Encapsulated mRNA Encoding Human OX40L, for Intratumoral Injection Alone and in Combination with Durvalumab for Patients wit

Project: Research project

Project Details

Effective start/end date11/11/2011/11/23


  • PPD Investigator Services, LLC (Prot #mRNA-2416-P101)
  • ModernaTX, Inc (Prot #mRNA-2416-P101)